Orteronel for Metastatic Hormone-Sensitive Prostate Cancer: A Multicenter, Randomized, Open-Label Phase III Trial (SWOG-1216)
Authors: Harzstark, Andrea L | Journal Of Clinical Oncology : Official Journal Of The American Society Of Clinical Oncology | April 21, 2022 | PubMed abstract
